136 related articles for article (PubMed ID: 37951787)
1. Palliative care needs among outpatient adults with cystic fibrosis: Baseline data from the Improving Life with CF trial.
DiFiglia S; Georgiopoulos AM; Portenoy R; Seng E; Berdella M; Friedman D; Kier C; Linnemann RW; Middour-Oxler B; Walker P; Wang J; Yonker LM; Buehler B; Chaudhary N; Esposito C; Frantzen T; Henthorne K; Plachta A; Pollinger S; Stables-Carney T; Trentacoste J; Dhingra L
J Cyst Fibros; 2023 Nov; ():. PubMed ID: 37951787
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Integrated Palliative Care Outcome Scale (IPOS) in adults with cystic fibrosis.
Georgiopoulos AM; DiFiglia S; Seng EK; Portenoy R; Chaudhary N; Wei R; Berdella MN; Friedman D; Kier C; Linnemann RW; Middour-Oxler B; Stables-Carney T; Walker P; Wang J; Yonker LM; Dhingra L
Pediatr Pulmonol; 2024 Jun; ():. PubMed ID: 38934771
[TBL] [Abstract][Full Text] [Related]
3. A grumbling concern: an international survey of gastrointestinal symptoms in cystic fibrosis in the modulator era.
Calthorpe RJ; Goodchild N; Gleetus V; Premakumar V; Hayee B; Elliott Z; Evans B; Rowbotham NJ; Carr SB; Barr H; Horsley A; Peckham D; Smyth AR
NIHR Open Res; 2023; 3():18. PubMed ID: 37881465
[TBL] [Abstract][Full Text] [Related]
4. Addressing Symptom Burden and Palliative Care Needs in Cystic Fibrosis: A Narrative Review of the Literature.
DiFiglia S; Dhingra L; Georgiopoulos AM; Papia K; Sullivan E; Plachta A; Boccio C; Portenoy R; Basile M
Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629478
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of unmet palliative care needs in adults with cystic fibrosis.
Trandel ET; Pilewski JM; Dellon EP; Jeong K; Yabes JG; Moreines LT; Arnold RM; Hoydich ZP; Kavalieratos D
J Cyst Fibros; 2020 May; 19(3):394-401. PubMed ID: 31862306
[TBL] [Abstract][Full Text] [Related]
6. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
7. Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Marsh R; Dos Santos C; Hanson L; Ng C; Major G; Smyth AR; Rivett D; van der Gast C
Microbiol Spectr; 2023 Aug; 11(5):e0117523. PubMed ID: 37607068
[TBL] [Abstract][Full Text] [Related]
8. A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators.
Kramer-Golinkoff E; Camacho A; Kramer L; Taylor-Cousar JL
Pediatr Pulmonol; 2022 May; 57(5):1253-1261. PubMed ID: 35170259
[TBL] [Abstract][Full Text] [Related]
9. Symptoms and quality of life in adults with cystic fibrosis: A cross-sectional analysis of the InSPIRe:CF trial.
Smirnova N; Lowers J; Cammarata-Mouchtouris A; Dellon EP; Fitzpatrick A; Kavalieratos D
J Cyst Fibros; 2024 Mar; ():. PubMed ID: 38461123
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis.
Westhölter D; Beckert H; Straßburg S; Welsner M; Sutharsan S; Taube C; Reuter S
J Cyst Fibros; 2021 Nov; 20(6):1072-1079. PubMed ID: 34030985
[TBL] [Abstract][Full Text] [Related]
11. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis.
Ramsey ML; Gokun Y; Sobotka LA; Wellner MR; Porter K; Kirkby SE; Li SS; Papachristou GI; Krishna SG; Stanich PP; Hart PA; Conwell DL; Lara LF
Am J Gastroenterol; 2021 Dec; 116(12):2446-2454. PubMed ID: 34665155
[TBL] [Abstract][Full Text] [Related]
12. Lung Transplantation in a New Era in the Field of Cystic Fibrosis.
Huang W; Smith AT; Korotun M; Iacono A; Wang J
Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511977
[TBL] [Abstract][Full Text] [Related]
13. Development of a Cystic Fibrosis Primary Palliative Care Intervention: Qualitative Analysis of Patient and Family Caregiver Preferences.
Basile MJ; Dhingra L; DiFiglia S; Polo J; Portenoy R; Wang J; Walker P; Middour-Oxler B; Linnemann RW; Kier C; Friedman D; Berdella M; Abdullah R; Yonker LM; Markovitz M; Hadjiliadis D; Shiffman M; Fischer F; Pollinger S; Hardcastle M; Chaudhary N; Georgiopoulos AM
J Patient Exp; 2023; 10():23743735231161486. PubMed ID: 36936380
[TBL] [Abstract][Full Text] [Related]
14. Cystic Fibrosis Transmembrane Regulator Modulators: Implications for the Management of Depression and Anxiety in Cystic Fibrosis.
Talwalkar JS; Koff JL; Lee HB; Britto CJ; Mulenos AM; Georgiopoulos AM
Psychosomatics; 2017; 58(4):343-354. PubMed ID: 28576305
[TBL] [Abstract][Full Text] [Related]
15. Airway clearance after highly effective CFTR modulators: Normalizing life and reducing treatment burden.
Goetz DM; Frederick CK; Perez G; Borowitz D
Pediatr Pulmonol; 2023 Aug; 58(8):2375-2380. PubMed ID: 37232336
[TBL] [Abstract][Full Text] [Related]
16. Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies.
Carbone A; Vitullo P; Di Gioia S; Conese M
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895314
[TBL] [Abstract][Full Text] [Related]
17. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
18. Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy.
Gifford AH; Mayer-Hamblett N; Pearson K; Nichols DP
J Cyst Fibros; 2020 Sep; 19(5):762-767. PubMed ID: 31761739
[TBL] [Abstract][Full Text] [Related]
19. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
[TBL] [Abstract][Full Text] [Related]
20. Addressing the burden of illness in adults with cystic fibrosis with screening and triage: An early intervention model of palliative care.
Dhingra L; Walker P; Berdella M; Plachta A; Chen J; Fresenius A; Balzano J; Barrett M; Bookbinder M; Wilder K; Glajchen M; Langfelder-Schwind E; Portenoy RK
J Cyst Fibros; 2020 Mar; 19(2):262-270. PubMed ID: 31471264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
